Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin N Am 2005;19:803-26.10.1016/j.hoc.2005.07.002Search in Google Scholar
Rosse WF, Telen MJ, Ware RE. Transfusion support for patients with sickle cell disease. Bethesda, MD, AABB Press: 1998.Search in Google Scholar
Triluzi DJ. Blood transfusion therapy: a physician’s handbook. 7th ed. Bethesda MD, AABB Press: 2002;111-6.Search in Google Scholar
Talano JA, Hillery CA, Gottsschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:661-5.10.1542/peds.111.6.e661Search in Google Scholar
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype matched RBC’s to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-91.10.1046/j.1537-2995.2002.00126.xSearch in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective red blood cell phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41:1086-92.10.1046/j.1537-2995.2001.41091086.xSearch in Google Scholar
Nizzi F. Medical Director, Carter BloodCare at Childrens. Personal communication. 2004.Search in Google Scholar
Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-42.10.1182/blood.V83.4.1136.1136Search in Google Scholar
Bruce C. McLeod, editor. Therapeutic apheresis: a physicians handbook. 1st ed. Bethesda MD, AABB Press: 2005;120-7, 146-50.Search in Google Scholar
Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003; 289:1645-51.10.1001/jama.289.13.1645Search in Google Scholar
Ohene-Frempong K, Weiner SJ, Sleeper, LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.Search in Google Scholar
Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-52.10.1016/j.jpeds.2004.04.058Search in Google Scholar
Wang WC, Kovnar EH, Tonkin IL, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;118: 377-82.10.1016/S0022-3476(05)82150-XSearch in Google Scholar
Cohen AR, Martin MB, Silber JH et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-61.10.1182/blood.V79.7.1657.1657Search in Google Scholar
Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle-cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339: 5-11.10.1056/NEJM1998070233901029647873Search in Google Scholar
Miller St, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-9.10.1067/mpd.2001.119593Search in Google Scholar
Mantadakis E, Ewalt DH, Cavender JD, et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000; 95:78-82.10.1182/blood.V95.1.78Search in Google Scholar
Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: Aspen syndrome. J Urol 1993;150:1480-2.10.1016/S0022-5347(17)35817-2Search in Google Scholar
Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-13.10.1056/NEJM1995072733304027791837Search in Google Scholar
Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR. Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion. Pediatr Blood Cancer 2005;45:43-7.10.1002/pbc.2028315880471Search in Google Scholar
Package insert: Exjade (deferasirox). Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. November 2005.Search in Google Scholar
